Biomarkers for Personalised Primary or Secondary Prevention in Cardiovascular Diseases: A Rapid Scoping Review
Authors:
- Chantal Babb de VilliersCVChantal Babb de Villiers
- Elena Plans-BerisoEPElena Plans-Beriso
- Chaitanya EradyCEChaitanya Erady
- Laura BlackburnLBLaura Blackburn
- Hayley WilsonHWHayley Wilson
- Heather TurnerHTHeather Turner
- Isla KuhnIKIsla Kuhn
- Cristina Barahona-LópezCBCristina Barahona-López
- Paul Diez-EchavePDPaul Diez-Echave
- Orlando Romulo HernándezOHOrlando Romulo Hernández
- Nerea Fernández de Larrea-BazNLNerea Fernández de Larrea-Baz
- Dafina PetrovaDPDafina Petrova
Open Access
- 24 September 2025
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (19) , 9346
Abstract
Cardiovascular diseases (CVDs) are the leading cause of morbidity and mortality globally. Early detection and personalised prevention strategies are crucial for reducing the burden of CVD. The use of biomarkers plays a pivotal role in identifying individuals at risk and facilitating timely interventions. This rapid scoping review aims to identify and evaluate current research on biomarkers used for primary and secondary personalised prevention of CVD, highlighting evidence gaps and the integration of digital technologies. A comprehensive search was conducted in Medline and Embase databases from January 2020 to February 2023. Joanna Briggs Institute (JBI) Manual for Evidence Synthesis and PRISMA-ScR guidelines were followed. A total of 775 studies were included, with ischemic heart disease (IHD) and stroke being the most investigated CVDs. Molecular, cellular, imaging, physiological, and anthropometric biomarkers were included. Molecular biomarkers, particularly genetic and biochemical, were the most researched. For secondary prevention, there was considerable research using imaging biomarkers. Genetic biomarker research was the most frequent category of biomarker identified, particularly using variant analysis and polygenic scores, followed by biochemical, imaging, and physiological biomarkers. There was also evidence of the integration of artificial intelligence to enhance the predictive capabilities of these biomarkers. Despite progress, research gaps were identified for less common CVDs, such as aortic aneurysm and nonrheumatic valvular heart disease, and limited research investigating other molecular biomarker types, such as epigenetics and transcriptomics.Keywords
Funding Information
- H2020 Health (101057721, 10040946, CP23/00024)
- H2020 Health (101057721, 10040946, CP23/00024)
- UK Research and Innovation (101057721, 10040946, CP23/00024)
- Health Institute Carlos III (Spain) (101057721, 10040946, CP23/00024)
This publication has 65 references indexed in Scilit:
- Integrating oculomics with genomics reveals imaging biomarkers for preventive and personalized prediction of arterial aneurysmsEPMA Journal, 2023
- Citationchaser: A tool for transparent and efficient forward and backward citation chasing in systematic searchingResearch Synthesis Methods, 2022
- Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019JAMA Oncology, 2021
- Comparison of choroidal thicknesses in patients with coronary artery disease and patients at risk of coronary artery diseaseInternational Ophthalmology, 2021
- Global mortality from dementia: Application of a new method and results from the Global Burden of Disease Study 2019Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2021
- Cardiovascular health in early adulthood predicts the development of coronary heart disease in individuals with type 1 diabetes: 25 year follow-up from the Pittsburgh Epidemiology of Diabetes Complications studyDiabetologia, 2020
- Predictors of abnormality in thallium myocardial perfusion scans for type 2 diabetesHeart and Vessels, 2020
- Association of genetic variants in lncRNA GAS5/miR‐21/mTOR axis with risk and prognosis of coronary artery disease among a Chinese populationJournal of Clinical Laboratory Analysis, 2020
- Association Between Caliber of Retinal Vessels and Cardiovascular Disease: a Systematic Review and Meta-AnalysisCurrent Atherosclerosis Reports, 2020
- A potent risk model for predicting new-onset acute coronary syndrome in patients with type 2 diabetes mellitus in Northwest ChinaActa Diabetologica, 2020